Litcius/Paper detail

Endocrine therapies for breast and prostate cancers

Geneviève Chaput, Nureen Sumar

2022Canadian Family Physician23 citationsDOIOpen Access PDF

Abstract

Breast and prostate cancers are the most common cancers in Canada, occurring in approximately 1 in 8 women and 1 in 8 men, respectively.[1][1] The predicted 5-year survival rate for patients with either cancer is approximately 90%.[1][1] Endocrine therapy is a mainstay treatment for the management

Topics & Concepts

Endocrine systemMedicineProstate cancerOncologyProstateBreast cancerInternal medicineCancerGynecologyBioinformaticsHormoneBiologyAdvanced Breast Cancer TherapiesBreast Cancer Treatment StudiesProstate Cancer Treatment and Research
Endocrine therapies for breast and prostate cancers | Litcius